Drug Repurposing and Lysosomal Storage Disorders: A Trick to Treat
Rare diseases, or orphan diseases, are defined as diseases affecting a small number of people compared to the general population. Among these, we find lysosomal storage disorders (LSDs), a cluster of rare metabolic diseases characterized by enzyme mutations causing abnormal glycolipid storage. Drug...
Main Authors: | Bruno Hay Mele, Federica Rossetti, Maria Vittoria Cubellis, Maria Monticelli, Giuseppina Andreotti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/15/3/290 |
Similar Items
-
Curcumin Has Beneficial Effects on Lysosomal Alpha-Galactosidase: Potential Implications for the Cure of Fabry Disease
by: Maria Monticelli, et al.
Published: (2023-01-01) -
Drug Repositioning for Fabry Disease: Acetylsalicylic Acid Potentiates the Stabilization of Lysosomal Alpha-Galactosidase by Pharmacological Chaperones
by: Maria Monticelli, et al.
Published: (2022-05-01) -
Induced pluripotent stem cell models of lysosomal storage disorders
by: Daniel K. Borger, et al.
Published: (2017-06-01) -
The rapidly evolving view of lysosomal storage diseases
by: Giancarlo Parenti, et al.
Published: (2021-02-01) -
Potential Treatment of Lysosomal Storage Disease through Modulation of the Mitochondrial—Lysosomal Axis
by: Myeong Uk Kuk, et al.
Published: (2021-02-01)